Antimalarial drugs: Double whammy

Abstract

deadly form of which is caused by the parasite Plasmodium falciparum — are required to combat the emergence of resistance to standard therapies such as chloroquine. In a recent article in Nature, Kelly and colleagues report promising results on a newly synthesized dual-action compound designed to help meet this medical need. During the erythrocytic phase of… (More)
DOI: 10.1038/nrd2902

Topics

  • Presentations referencing similar topics